Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Denosumab treatment for osteoporosis can cause hair loss.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Andrographolide-loaded topical nanocarriers are a safe and effective treatment for psoriasis.

HS needs personalized treatment plans and more research.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Dupilumab users have a higher risk of developing alopecia areata.

Testosterone therapy significantly improved Hidradenitis Suppurativa symptoms.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Belatacept may be a promising treatment for alopecia areata.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Methotrexate is effective, safe, and affordable for treating skin conditions in children.

Systemic isotretinoin is very effective for treating dissecting cellulitis of the scalp.